birth control recall
birth control recall - Nationwide recall of birth control pill after packaging error - the SECOND in a month
Yet more birth control pills have been recalled after a packaging error - just weeks after Pfizer recalled almost one million packets of pills.
Glenmark Generics has recalled its oral contraceptives after a packaging error landed the pills in the wrong order in their packets.
The seven lots of norgestimate and ethinyl estradiol tablets were distributed to U.S. pharmacies between September and December 2011.The India-based company has warned the tablets 'could leave women without adequate contraception, and at risk for unintended pregnancy'.
Glenmark has not revealed the number of packets affected.
The packs contain three types of pills with different levels of hormones, designed to be taken at different times during a woman's cycle.
But an error occurred when 'select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch'.
It means that women will be taking pills in the wrong order during their monthly cycle, and the contraceptives may not be effective.
The affected lot numbers are 04110101, 04110106, 04110107, 04110114, 04110124, 04110129 and 04110134.
'Patients who have the affected product should notify their physician and return the product to the pharmacy' and 'begin using a nonhormonal form of contraception immediately,' the company added.
The mistake was discovered when a woman complained she had received a pack in which the tablets were packaged in reverse order.
The correct packaging lines 28 tablets in four rows, with white tablets containing norgestimate and ethinyl estradiol in the top row and light green placebo tablets in the bottom row.
It comes after Pfizer recalled 28 lots of generic birth control pills labeled Norgestrel and Ethinyl Estradiol tablets last month.
The company had discovered some packs contained tablets that were out of sequence or an inexact count of inert or active ingredient tablets.